JPMorgan BetaBuilders International Equity ETF
BBIN
Chicago Board Options Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Nicholas Galakatos
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 383 Madison Avenue New York NY United States of America 10179
- IPO Date
- Dec 9, 2019
- CIK
- 0001485894
- Website
- am.jpmorgan.com
- Similar Companies
- Business
- JPMorgan BetaBuilders International Equity ETF (BBIN) is an exchange-traded fund that seeks to provide investment results corresponding to the Morningstar Developed Markets ex-North America Target Market Exposure Index, a free-float adjusted market capitalization-weighted index of large- and mid-cap equities from developed markets outside the United States and Canada, representing the top 85% of the investable universe by float-adjusted market capitalization. The ETF employs a passive investment approach to replicate the index, holding approximately 688-702 securities across sectors including financials (24.4%), industrials (19.3%), consumer discretionary (10.1%), health care (11.1%), and information technology (8.4%), with top holdings such as ASML Holding NV (2.1%), SAP SE (1.4%), AstraZeneca PLC (1.3%), Nestle SA (1.3%), and HSBC Holdings PLC (1.3%). It offers investors low-cost exposure to international developed market equities with a net expense ratio of 0.07%, assets under management of approximately $5.89-$6.07 billion, and a 30-day SEC yield of 2.89% as of October 2025. Launched on December 3, 2019, by J.P. Morgan Asset Management, a division of JPMorgan Chase & Co., BBIN is part of the J.P. Morgan Exchange-Traded Fund Trust and trades on the Cboe BATS exchange under the ticker BBIN (CUSIP: 46641Q373). The fund targets institutional and retail investors seeking diversified exposure to developed markets in regions including Japan (24.5% allocation), United Kingdom (14.7%), France (9.5%), Germany (9.1%), Switzerland (9.0%), Australia (6.8%), and Netherlands (6.0%), excluding North America and small-cap stocks. Portfolio management is led by experienced professionals including Nicholas D'Eramo (28 years), Michael Loeffler (28 years), and Todd McEwen (20 years). Recent developments include significant asset growth, with fund assets expanding from lower levels to nearly $6 billion amid strong inflows of $819.27 million over the past year, reflecting investor demand for cost-efficient international equity exposure. The ETF maintains its Bronze Morningstar Medalist Rating as of September 30, 2025, with a 4-star overall Morningstar rating in the Foreign Large Blend category, driven by competitive risk-adjusted performance. No major acquisitions, partnerships, or structural changes have been announced for BBIN in the last 1-2 years; it continues to operate as a stable, index-tracking vehicle within JPMorgan's BetaBuilders suite, with quarterly rebalancing and ongoing portfolio adjustments such as new positions in Sigma Healthcare Limited and BioNTech SE.